All about COVID-19

Coronavirus | Is the first wave coming to an end in India?

Hopeful decline: The only reasonable explanation is that besides other factors, the threshold for population immunity has been reached, inefficient testing strategy, better compliance to regulations or a combination of these.   | Photo Credit: Getty Images_Suprabhat Dutta

Though the total number of coronavirus cases in India has crossed 10.1 million, the number of daily fresh cases has been steadily dropping from a peak of nearly 98,000 cases on September 16 to below 25,000 daily cases in the last few days; December 25 recorded 22,350 fresh cases. The steady drop in cases has been seen nationally without much of a spike since mid-September notwithstanding the festival season, winter and large gatherings, whether political or otherwise. The absence of a spike is all the more surprising as strict adherence to non-pharmaceutical interventions (NPIs) has been far from good. Does the steadily declining trend in daily cases and absence of a spike nationally then suggest that the first wave is slowly coming to an end in India?

“It would be inaccurate to infer at the national level while some of the north-eastern States have a cumulative test positivity rate above 8%. Even at national level, the cumulative test positivity rate is 6.1% as on December 23, which suggests we aren’t near the end immediately,” Dr. Giridhara Babu, Professor of Epidemiology at the Public Health Foundation of India, Bengaluru, and a member of the Karnataka COVID-19 Technical Advisory Committee says in an email.

The cumulative test positivity rate should be less than 5% to say that transmission has been contained. The reason: the seven day or monthly positivity rate only indicates active surge in cases as seen now in some north-east States, while the cumulative test positivity rate reflects the overall containment in transmission.

Note of caution

Gautam Menon, Professor of Physics and Biology at Ashoka University and co-author of COVID-19 modelling studies cautions in an email that test positivity is large in a number of States, including Kerala and Maharashtra, which were hard hit earlier as well. “This suggests that the disease is still spreading, although more slowly. I think this is mainly evidence that COVID-19 is no longer primarily spreading in more urban areas, so this should be expected to mark a qualitative change. In that sense, it can be thought of as an end to the ‘first wave’,” he says.

“The decline has been steady and prolonged, with the fall somewhat slower than the rise. Within this fall in national figures there are small regional spikes and that will continue to happen in the days to come,” says virologist Dr. Shahid Jameel, Director of the Trivedi School of Biosciences at Ashoka University.

Explaining that natural infection (both detected and undetected) has not reached the level to confer herd immunity and cause a slowdown in daily cases, Dr. Menon says: “My own guess would be that about 40–50% of urban India, in particular tier-1 and tier-2 cities has been infected at this point, while an India-wide number is more likely in the range of 30-40%. This is still below what might be a herd immunity threshold, although it would be consistent with a decrease in the number of daily cases, as is being seen.”

Dr. Jameel too feels only about 30% of people across India have been infected while positivity is somewhere in the range of 50% in large dense cities. “It is hard to say [if natural infection has come close to providing herd immunity] unless another more representative serosurvey is carried out,” Dr. Jameel says.

Reasonable explanation

The only reasonable explanation for a drop in daily cases without any spike even after Durga pooja and Diwali is that besides other factors, the threshold for population immunity attributed to has been reached, inefficient testing strategy, better compliance to regulations or a combination of these, feels Dr. Babu.

Sufficient adherence

“My only guess is that adherence to NPIs, although not ideal, was sufficient to slow down the spread and state governments did institute some reasonable measures to curb spread during festivals. Certainly, anecdotal evidence suggests that although crowds did build up in festival season, mask wearing was reasonably common,” says Dr. Menon. “The other possibility is that in regions which saw the largest crowds, as for example Kolkata's Durga Puja pandals, this was in the background of a large fraction of people with prior infections already, so this would have also hampered unrestricted spread.”

Explaining why daily cases in Kerala are still high while other States including Maharashtra, Tamil Nadu, Andhra Pradesh and Karnataka that had earlier reported high number of cases have seen a sharp drop, Dr. Menon says: “I would attribute this to the fact that the spread in Kerala started somewhat later than other regions and the fact that Kerala is fairly urbanised in comparison to most other states.”

Dr. Babu feels the sharp drop in Maharashtra and the three southern States is mostly because a reasonable proportion of people living in urban areas have been infected. He attributes the relatively high daily cases in Kerala to effective control of virus spread from the beginning. “This meant that a large proportion of people in Kerala remained uninfected in the initial stages. It is supported by the seroprevalence rate of 0.8% which is much lower than other States. It meant getting infected at some point,” Dr. Babu explains. “The tests done in Kerala are 2,08,100 per million, and is among the States with the best rates. It is because of this that the State is detecting more cases. Reporting more cases should not be seen as a problem.”

Though the number of cases appear to be dropping in the three southern States, the test positivity rate is still avove 5%. As on December 23 the cumulative test positivity rates in Karnataka, Tamil Nadu and Andhra Pradesh were 7%, 5.78% and 8%, respectively. “In addition to the numbers, testing the right persons (with symptoms), using the right test and improving the geographical coverage is important. Most tests are done in metros and tier1 cities with relatively less number in other areas. It is not efficient to increase tests in areas where the surge has already occurred in the past. This is a dynamic decision. Karnataka used the survey results to make these revisions in testing strategy for districts. Others states can follow similar strategy,” says Dr. Babu.

Dr. Babu attributes the over 180 cases reported in IIT Madras even as Tamil Nadu has reporting a steady decline in cases as an instance of an island of susceptible people in close contact settings and closed spaces serving as a potential cluster waiting to be triggered by introduction of infection.

“The solution to this is periodic testing at a density where you can pick infections early and isolate infected people. Many western universities have started doing this and various plans are available. At Ashoka University we have an elaborate plan to screen students as they come in for the coming semester,” says Dr. Jameel.

Our code of editorial values

This article is closed for comments.
Please Email the Editor

Printable version | Jan 25, 2022 11:38:07 PM |

In This Package
The Hindu Explains | How is India preparing to roll out COVID-19 vaccines?
The Hindu Explains | Why was a COVID-19 vaccine dry run necessary, and how was it organised?
Coronavirus | Why people with prior infection still need COVID-19 vaccination
Explained | What we know about China-made vaccines
How infections among participants are a part of vaccine trials | The Hindu In Focus podcast
The Hindu Explains | What is emergency use authorisation for drugs and vaccines?
Coronavirus | How the new variant quickly accumulated 23 mutations
Coronavirus | New variant does not increase reinfection risk, disease severity, deaths
Coronavirus | N501Y mutation in SARS-CoV-2 virus causes increased infectivity in mice: researchers
The Hindu Explains | Are viruses expected to change form, and will vaccines protect against a mutating SARS-CoV-2?
You are reading
Coronavirus | Is the first wave coming to an end in India?
Has India passed the COVID-19 peak? | The Hindu Parley podcast
Has India passed its COVID-19 peak, as a new government study claims? | The Hindu In Focus podcast
No evidence to suggest coronavirus cluster 5 variant found in minks increases virus transmissibility, disease severity
SARS-CoV-2 not the last virus to spark a pandemic, says expert
The Hindu Explains | Who are the top contenders in the race for a COVID-19 vaccine?
The vaccine networks India will rely on and the challenges ahead | The Hindu In Focus podcast
Study advances use of indomethacin for treatment of mild cases
How an asymptomatic player turned super-spreader
How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast
WHO warns against pursuing herd immunity to stop coronavirus
Studies document in-flight transmission of coronavirus
Experimental study finds how coronavirus can spread while speaking
Can universal masking be a crude ‘vaccine’?
The Hindu Explains | Is COVID-19 setting off a bradykinin storm in the body?
Coronavirus | Lung damage in COVID-19 dead may shed light on ‘long COVID’: study
The Hindu Explains | What does herd immunity mean for COVID-19?
The Hindu Explains | What do we know about Russia’s COVID-19 vaccine candidate Sputnik V?
Coronavirus | Russian vaccine generated strong immune response, says Lancet study
Watch | Is COVID-19 intensifying in rural India?
The Hindu Explains | Why is Phase-3 of COVID-19 vaccine trial complicated?
The Hindu Explains | What are the long-term effects of COVID-19?
The Hindu Explains | Are there re-infection fears around COVID-19?
Watch | COVID-19 and children
The Hindu Explains | Is SARS-CoV-2 a latent virus which can recur?
Watch | What is an immunity passport?
WHO says COVID-19 by far its worst global health emergency
CDC says revised guidance on coronavirus spread posted in error, removes it
Coronavirus | Plasma therapy may look promising in treating COVID-19, but it is no magic bullet
Coronavirus | Different kinds of SARS-CoV-2 exist in India but none more lethal than the other: Indian Academy of Sciences President
The Hindu Explains | Is airborne transmission of COVID-19 a risk?
Watch | What are serological surveys?
The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?
Video: In conversation with Andrew Pollard, Director of Oxford Vaccine Group
Watch | All you need to know about pulse oximeters
Coronavirus | Why are only a fraction of cases tested?
Coronavirus | Vaccine was rapidly synthesised as novel coronavirus sequence was available, says virologist Gagandeep Kang
A step closer to developing a potent drug against novel coronavirus
Coronavirus | The importance of ‘contact tracing’
Coronavirus | Are diabetics more prone to COVID-19?
Private firms ready to test for COVID-19
Coronavirus | How does soap use help in tackling COVID-19?
Fight for the finite: On budgetary allocation for health
Coronavirus | A problematic testing strategy
Fighting COVID-19 together for a shared future
Scientists get ready to test rival COVID-19 pandemic vaccines in animals
Coronavirus | The cost of opacity
Watch | COVID-19: Masks and sanitisers are now essential commodities
A COVID-19 control plan made simple
Watch | Your COVID-19 queries answered
Coronavirus | How is India containing COVID-19?
Battle against COVID-19
Watch | COVID-19: Dos and don'ts from the Health Ministry
A COVID-19 response that is quick off the blocks
Watch | Why is COVID-19 not a pandemic yet?
Watch | Coronavirus: Can masks protect you?
Watch | How is India dealing with coronavirus?
WHO’s unexplained hesitancy
Watch | Bats and the novel coronavirus
Coronavirus | India shares two SARS-CoV-2 genome sequences
COVID-19 | We are in uncharted territory, says WHO
Explained | Why is COVID-19 not a pandemic yet?
New COVID-19 epidemic at ‘decisive point’: WHO chief
COVID-19 vaccine may be ready by 2022: SII
Explainer: How WHO names a new disease
WHO names deadly viral disease from China as 'COVID-19'
Explained | When can people transmit the novel coronavirus?
Analysis | For China’s Xi, the coronavirus challenge comes laden with economic costs and political risks
How bats harbour several viruses yet not get sick
WHO declares coronavirus outbreak a global emergency
Watch | What is Coronavirus?
What is the source of the new SARS-like disease reported in China?
Data | The wide, rapid spread of the novel coronavirus
Alarming spread: on novel coronavirus outbreak
Gaps in our knowledge of coronavirus origin need fulfilment: Study
A new virus emerges in China
Next Story